Major Review Of EU Pharmaceutical Legislation Kicks Off
Roadmap Published As Part Of EU Pharma Strategy
The European Commission has launched the process for reshaping and addressing the long-standing weakness in the EU’s pharmaceutical legislation. It has listed in a roadmap the issues it wants to address as it considers policy options for reforms.